首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

导出原文传递

翻译打印收藏纠错

第一作者： Martin,Stanulla

第一单位： Martin Stanulla, Elif Dagdan, Stefanie V. Junk, Laura Hinze, Norman Klein, Christian P. Kratz, Petra Dörge, Doris Steinemann, and Martin Zimmermann, Hannover Medical School; Petra Dörge, German Center for Infection Research, Hannover; Anja Möricke, Kirsten Bleckmann, Denis Schewe, Gunnar Cario, and Martin Schrappe, University Hospital Schleswig-Holstein; Britt-Sabina Petersen and Andre Franke, Kiel University, Kiel; Cornelia Eckert and Stefanie Groeneveld-Krentz, Charité University Hospital; Wolf-Dieter Ludwig, HELIOS-Clinic Berlin-Buch, Berlin; Rolf Koehler, Claus R. Bartram, Andreas Kulozik, and Martina U. Muckenthaler, University of Heidelberg, Heidelberg; Arndt Borkhardt, Heinrich-Heine University, Düsseldorf, Germany; Marketa Zaliova, Charles University and University Hospital Motol, Prague, Czech Republic; Chiara Palmi, Giovanni Cazzaniga, and Andrea Biondi, Azienda Ospedaliera San Gerardo; Maria Grazia Valsecchi, University of Milano-Bicocca, Monza; Geertruy te Kronnie and Giuseppe Basso, University of Padova, Padua, Italy; Jean-Pierre Bourquin and Beat Bornhauser, University Children's Hospital Zurich, Zurich, Switzerland; Shai Izraeli, Sheba Medical Center Tel-Hashomer and Tel Aviv University, Tel Aviv, Israel; Oskar A. Haas and Renate Panzer-Grümayer, St Anna Kinderkrebsforschung and Medical University Vienna, Vienna, Austria; Hélène Cavé, Robert Debré Hospital and Paris-Diderot University, Paris, France; and Richard S. Houlston, The Institute of Cancer Research, London, United Kingdom.

作者： Martin,Stanulla ^[1] ; Elif,Dagdan ^[1] ; Marketa,Zaliova ^[1] ; Anja,Möricke ^[1] ; Chiara,Palmi ^[1] ; Giovanni,Cazzaniga ^[1] ; Cornelia,Eckert ^[1] ; Geertruy,Te Kronnie ^[1] ; Jean-Pierre,Bourquin ^[1] ; Beat,Bornhauser ^[1] ; Rolf,Koehler ^[1] ; Claus R,Bartram ^[1] ; Wolf-Dieter,Ludwig ^[1] ; Kirsten,Bleckmann ^[1] ; Stefanie,Groeneveld-Krentz ^[1] ; Denis,Schewe ^[1] ; Stefanie V,Junk ^[1] ; Laura,Hinze ^[1] ; Norman,Klein ^[1] ; Christian P,Kratz ^[1] ; Andrea,Biondi ^[1] ; Arndt,Borkhardt ^[1] ; Andreas,Kulozik ^[1] ; Martina U,Muckenthaler ^[1] ; Giuseppe,Basso ^[1] ; Maria Grazia,Valsecchi ^[1] ; Shai,Izraeli ^[1] ; Britt-Sabina,Petersen ^[1] ; Andre,Franke ^[1] ; Petra,Dörge ^[1] ; Doris,Steinemann ^[1] ; Oskar A,Haas ^[1] ; Renate,Panzer-Grümayer ^[1] ; Hélène,Cavé ^[1] ; Richard S,Houlston ^[1] ; Gunnar,Cario ^[1] ; Martin,Schrappe ^[1] ; Martin,Zimmermann ^[1] ; TRANSCALL Consortium ; International BFM Study Group

作者单位： Martin Stanulla, Elif Dagdan, Stefanie V. Junk, Laura Hinze, Norman Klein, Christian P. Kratz, Petra Dörge, Doris Steinemann, and Martin Zimmermann, Hannover Medical School; Petra Dörge, German Center for Infection Research, Hannover; Anja Möricke, Kirsten Bleckmann, Denis Schewe, Gunnar Cario, and Martin Schrappe, University Hospital Schleswig-Holstein; Britt-Sabina Petersen and Andre Franke, Kiel University, Kiel; Cornelia Eckert and Stefanie Groeneveld-Krentz, Charité University Hospital; Wolf-Dieter Ludwig, HELIOS-Clinic Berlin-Buch, Berlin; Rolf Koehler, Claus R. Bartram, Andreas Kulozik, and Martina U. Muckenthaler, University of Heidelberg, Heidelberg; Arndt Borkhardt, Heinrich-Heine University, Düsseldorf, Germany; Marketa Zaliova, Charles University and University Hospital Motol, Prague, Czech Republic; Chiara Palmi, Giovanni Cazzaniga, and Andrea Biondi, Azienda Ospedaliera San Gerardo; Maria Grazia Valsecchi, University of Milano-Bicocca, Monza; Geertruy te Kronnie and Giuseppe Basso, University of Padova, Padua, Italy; Jean-Pierre Bourquin and Beat Bornhauser, University Children's Hospital Zurich, Zurich, Switzerland; Shai Izraeli, Sheba Medical Center Tel-Hashomer and Tel Aviv University, Tel Aviv, Israel; Oskar A. Haas and Renate Panzer-Grümayer, St Anna Kinderkrebsforschung and Medical University Vienna, Vienna, Austria; Hélène Cavé, Robert Debré Hospital and Paris-Diderot University, Paris, France; and Richard S. Houlston, The Institute of Cancer Research, London, United Kingdom. ^[1]